<GlossaryTerm id="CDR0000776962"><TermName>Tagrisso</TermName><TermPronunciation>(tuh-GRIH-soh)</TermPronunciation><TermDefinition><DefinitionText>A drug used alone or with other drugs to treat adults with certain types of non-small cell lung cancer that have an abnormal <GeneName>EGFR</GeneName> gene. It is also being studied in the treatment of other types of cancer. Tagrisso blocks certain proteins made by the mutated <GeneName>EGFR</GeneName> gene, which may help keep cancer cells from growing and may kill them. It is a type of tyrosine kinase inhibitor. Also called osimertinib mesylate.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000778393" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Tagrisso&quot;" language="en" id="_3"/><MediaLink ref="CDR0000778392" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Tagrisso&quot;" language="es" id="_4"/><SpanishTermName>Tagrisso</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa solo o con otros medicamentos para el tratamiento de adultos con algunos tipos de cáncer de pulmón de células no pequeñas que tienen un gen <GeneName>EGFR</GeneName> anormal. También está en estudio para el tratamiento de otros tipos de cáncer. Tagrisso bloquea ciertas proteínas que se originan del gen <GeneName>EGFR</GeneName> mutado, lo que quizás ayude a impedir la multiplicación de células cancerosas y las destruya. Es un tipo de inhibidor de tirosina–cinasas. También se llama mesilato de osimertinib.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2015-11-23</DateFirstPublished><DateLastModified>2024-02-22</DateLastModified><RelatedInformation><RelatedDrugSummaryRef UseWith="en" href="CDR0000776980" url="/about-cancer/treatment/drugs/osimertinib">Osimertinib Mesylate</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
